Objectives: Findings from observational studies and clinical trials on the associations between vitamin E and dementia remain controversial. Here we conducted a meta-analysis to determine the difference in blood tocopherols levels between patients with Alzheimer's disease (AD) or age-related poor cognitive function and healthy controls.Methods: Standardised mean difference (SMD) and 95% confidence intervals (CIs) were calculated and entered into a random effects model. Study quality, heterogeneity and publication bias were also investigated.Results: Thirty-one articles were included in the meta-analysis, which included analyses for α-, β-, γ- and δ-tocopherols. These results indicated that individuals with AD or age-related cognitive defici...
Background: Dementia is a syndrome characterized by progressive cognitive impairment that interferes...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the major cause of dementia. I...
tocopherols and the risk of cognitive impairment Dear Sir: In a recent issue of the Journal, Ravagli...
Objectives: Findings from observational studies and clinical trials on the associations between vita...
Background: High intake of vitamin E from food (tocopherol), but not from supplements (which usually...
AbstractVitamin E has recently been suggested to slow down the progression of Alzheimer's disease. C...
With the aging population, dementia emerges as a public health concern. In 2012, the Health and Reti...
AbstractIntroductionVitamin E family, composed by tocopherols and tocotrienols, is a group of compou...
Introduction: Higher brain tocopherol levels have been associated with lower levels of Alzheimer's d...
Abstract Tocopherols, strong antioxidants, may be useful in preventing dementia, but the epidemiolog...
Vitamin E, the main non-enzymatic lipophylic antioxidant in the human body, has a major role in prot...
Background: Vitamin E is a dietary compound that functions as an antioxidant scavenging toxic free r...
OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-r...
Theoretical thesis.Bibliography: pages 55-63.1. Introduction -- 1.1 Pathology -- 1.1.1 Beta-Amyloid ...
Background/Aims: Recent studies suggest that vitamin D metabolites may be important for preserving c...
Background: Dementia is a syndrome characterized by progressive cognitive impairment that interferes...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the major cause of dementia. I...
tocopherols and the risk of cognitive impairment Dear Sir: In a recent issue of the Journal, Ravagli...
Objectives: Findings from observational studies and clinical trials on the associations between vita...
Background: High intake of vitamin E from food (tocopherol), but not from supplements (which usually...
AbstractVitamin E has recently been suggested to slow down the progression of Alzheimer's disease. C...
With the aging population, dementia emerges as a public health concern. In 2012, the Health and Reti...
AbstractIntroductionVitamin E family, composed by tocopherols and tocotrienols, is a group of compou...
Introduction: Higher brain tocopherol levels have been associated with lower levels of Alzheimer's d...
Abstract Tocopherols, strong antioxidants, may be useful in preventing dementia, but the epidemiolog...
Vitamin E, the main non-enzymatic lipophylic antioxidant in the human body, has a major role in prot...
Background: Vitamin E is a dietary compound that functions as an antioxidant scavenging toxic free r...
OBJECTIVES: This study aims to compare the differential gene expression resulting from tocotrienol-r...
Theoretical thesis.Bibliography: pages 55-63.1. Introduction -- 1.1 Pathology -- 1.1.1 Beta-Amyloid ...
Background/Aims: Recent studies suggest that vitamin D metabolites may be important for preserving c...
Background: Dementia is a syndrome characterized by progressive cognitive impairment that interferes...
Alzheimer’s disease (AD) is a neurodegenerative disorder representing the major cause of dementia. I...
tocopherols and the risk of cognitive impairment Dear Sir: In a recent issue of the Journal, Ravagli...